Enablex became the property of Novartis earlier this year, when Pfizer sold it to avoid any marketing conflicts of interest when it acquired Pharmacia.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletinsRegister
Already registered?Sign in
Join a growing community of PRWeek comms professionals today
- Read more articles each month
- Sign up for free specialised news bulletins